Author: Zomedica Corp.

Posted Date:

May 8, 2026

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity

Zomedica Corp.

May 8, 2026
Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity

Zomedica Corp.

May 8, 2026
Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale

Zomedica Corp.

April 16, 2026
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform

Zomedica Corp.

March 18, 2026
Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity

Zomedica Corp.

March 16, 2026
Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th “Fourth Friday at Four” Investor Webinar

Zomedica Corp.

March 10, 2026
Zomedica Expands Distribution of TRUVIEW(R) Digital Microscopy Platform Through National Agreement with Moichor, a Leader in Veterinary Pathology

Zomedica Corp.

February 25, 2026
Zomedica Announces “Fourth Friday at Four” Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline

Zomedica Corp.

February 7, 2026
Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity

Zomedica Corp.

January 28, 2026
Zomedica Enters Contract Manufacturing and Services Agreement with Rahm Sensor Development to Expand Revenue Streams Beyond Animal Health

Zomedica Corp.

January 27, 2026